SCHEMBL2350430

SCHEMBL2350430

O=C(NCCN1CCOCC1)c1ccc2[nH]cnc2c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.60
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPK1 P28482 1/20 0.58
CD274 Q9NZQ7 6/20 0.57
HTR1A P08908 1/20 0.57
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
KCNH2 Q12809 1/20 0.57
PARP1 P09874 1/20 0.55
HPGD P15428 1/20 0.55
KDM4E B2RXH2 1/20 0.54
HPGDS O60760 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30265334 1.00 POLB (0.60) POLBCYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL30265188 0.91 POLB (0.60) POLBCYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL13373331 0.89 PARP1 (0.57) CYP1A2CYP2D6ALDH1A1PARP1HPGD
SCHEMBL16240465 0.86 KMT2A (0.47) POLBALDH1A1MAPK1HTR1APARP1
SCHEMBL30265074 0.85 TSHR (0.58) POLBCYP2D6ALDH1A1KDM4E
SCHEMBL14385060 0.83 ALDH1A1 (0.56) ALDH1A1
SCHEMBL4811540 0.82 POLB (0.60) POLBCYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL14430690 0.82 KMT2A (0.60) POLBALDH1A1PARP1KDM4E
SCHEMBL3736562 0.80 SMN1; SMN2 (0.51) ALDH1A1MAPK1CD274KDM4E
SCHEMBL30265367 0.80 HTT (0.61) POLBCYP1A2CYP2D6ALDH1A1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288425-B2 Benzimidazoles AVENTIS PHARMACEUTICALS INC. (US) 2012-10-16 US disclosed
WO-2011103018-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF HIGH POINT PHARMACEUTICALS, LLC (US) 2011-08-25 WO disclosed